GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

被引：0
|
作者：
Usama M. Fouda
Ahmed M. Sayed
Hesham S. Elshaer
Bahaa Eldin M. Hammad
Mona M. Shaban
Khaled A. Elsetohy
Mohamed A. Youssef
机构：
[1] Cairo University,Department of Obstetrics and Gynecology, Faculty of Medicine
[2] Kasr Al-Ainy Hospital,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
Cabergoline; IVF-ET; Ovarian hyperstimulation syndrome; GnRH antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pregnancy rates and risk of ovarian hyperstimulation syndrome (OHSS) in a fixed GnRH-antagonist versus GnRH-agonist protocol: randomized controlled trial including 1099 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Lossl, K.
    Praetorius, L.
    Zedeler, A.
    Bryndorf, T.
    Nilas, L.
    Pinborg, A.
    HUMAN REPRODUCTION, 2015, 30 : 94 - 95
  • [22] Cabergoline vs intravenous albumin or combination of both for prevention of the early onset ovarian hyperstimulation syndrome
    Soliman, Badeea
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2011, 16 (01) : 56 - 60
  • [23] Clinical outcome according to timing of cabergoline initiation for prevention of OHSS: a randomized controlled trial
    Seow, Kok-Min
    Lin, Yu-Hung
    Bai, Chyi-Huey
    Chen, Heng-Ju
    Hsieh, Bih-Chwen
    Huang, Lee-Wen
    Tzeng, Chii-Ruey
    Hwang, Jiann-Loong
    REPRODUCTIVE BIOMEDICINE ONLINE, 2013, 26 (06) : 562 - 568
  • [24] Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial
    Elnaz Salari
    Negar Ajabi Ardehjani
    Ladan Kashani
    Kasra Jafari
    Ashraf Moini
    Journal of Ovarian Research, 18 (1)
  • [25] Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): A potentially safer and more effective protocol
    Gaafar, Sherif
    El-Gezary, Dalal
    El Maghraby, Hassan A.
    REPRODUCTIVE BIOLOGY, 2019, 19 (02) : 145 - 148
  • [26] Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Bryndorf, T.
    Lossl, K.
    Roskaer, J.
    Holland, T.
    Praetorius, L.
    Zedeler, A.
    Nilas, L.
    Pinborg, A.
    HUMAN REPRODUCTION, 2016, 31 (06) : 1253 - 1264
  • [27] Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection
    Taheripanah, Robabeh
    Vasef, Mahshid
    Zamaniyan, Marzieh
    Taheripanah, Anahita
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2018, 12 (01) : 1 - 5
  • [28] GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial
    Cheung, LP
    Lam, PM
    Lok, IH
    Chiu, TTY
    Yeung, SY
    Tjer, CC
    Haines, CJ
    HUMAN REPRODUCTION, 2005, 20 (03) : 616 - 621
  • [29] Efficacy of Combined Cabergoline and Metformin Compared to Metformin Alone on Cycle Regularity in Patients with Polycystic Ovarian Disease with Hyperprolactinemia: A Randomized Clinical Trial
    Elsersy M.A.M.
    The Journal of Obstetrics and Gynecology of India, 2017, 67 (5) : 363 - 369
  • [30] GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports
    Bakas, P.
    Boutas, I.
    Giner, M.
    Panagopoulos, P.
    Aravantinos, L.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2017, 44 (02) : 279 - 282
12345